Upregulation of hypoxia-induced mitogenic factor in bacterial lipopolysaccharide-induced acute lung injury

FEBS Letters

Volumn 580, Issue 9, 2006, Pages 2207-2215

  Tong, Qiangsong ^a   Zheng, Liduan ^b   Kang, Qiaohua ^a   Dodd o, Jeffrey ^c   Langer, John ^c   Li, Bo ^a   Wang, Danming ^a   Li, Dechun ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNION HOSPITAL   (China)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Acute lung injury; Gene expression; Hypoxia induced mitogenic factor; Lipopolysaccharide

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HYPOXIA INDUCED MITOGENIC FACTOR; MITOGENIC AGENT; SURFACTANT PROTEIN C; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; HEART; INJECTION; KIDNEY; LIVER; LUNG ALVEOLUS CELL TYPE 2; LUNG PARENCHYMA; LUNG SEQUESTRATION; MALE; MONONUCLEAR CELL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; SPLEEN; UPREGULATION;

ACUTE DISEASE; ANIMALS; CELL DEATH; INFLAMMATION; KIDNEY; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LIVER; LUNG; MALE; MICE; MYOCARDIUM; NERVE GROWTH FACTOR; ORGAN SPECIFICITY; PEPTIDES; PNEUMONIA; PROTEINS; SPLEEN; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 33646424352     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.03.027     Document Type: Article

References (21)

1. Wu Y., Singer M., Thouron F., Alaoui-El-Azher M., and Touqui L. Effect of surfactant on pulmonary expression of type IIA PLA2 in an animal model of acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 282 (2002) L743-L750
2. Bernard G.R., Artigas A., Brigham K.L., Carlet J., Falke K., Hudson L., Lamy M., Legall J.R., Morris A., and Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir Crit. Care Med. 149 (1994) 818-824
3. Agorreta J., Garayoa M., Montuenga L.M., and Zulueta J.J. Effects of acute hypoxia and lipopolysaccharide on nitric oxide synthase-2 expression in acute lung injury. Am. J. Respir. Crit. Care Med. 168 (2003) 287-296
4. Jeyaseelan S., Chu H.W., Young S.K., and Worthen G.S. Transcriptional profiling of lipopolysaccharide-induced acute lung injury. Infect. Immun. 72 (2004) 7247-7256
5. Teng X., Li D., Champion H.C., and Johns R.A. FIZZ1/RELM{α}, a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties. Circ. Res. 92 (2003) 1065-1067
6. Holcomb I.N., Kabakoff R.C., Chan B., Baker T.W., Gurney A., Henzel W., Nelson C., Lowman H.B., Wright B.D., Skelton N.J., Frantz G.D., Tumas D.B., Peale J., Shelton D.L., and Hebert C.C. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19 (2000) 4046-4055
7. Li D., Fernandez L.G., Dodd-o J., Langer J., Wang D., and Laubach V.E. Upregulation of hypoxia-induced mitogenic factor in compensatory lung growth after pneumonectomy. Am. J. Respir. Cell Mol. Biol. 32 (2005) 185-191
8. Tong Q., Zheng L., Dodd-o J., Langer J., Wang D., and Li D. Hypoxia-induced mitogenic factor modulates surfactant protein B and C expression in mouse lung. Am. J. Respir. Cell Mol. Biol. 34 (2006) 28-38
9. Leers M.P., Kolgen W., Bjorklund V., Bergman T., Tribbick G., Persson B., Bjorklund P., Ramaekers F.C., Bjorklund B., Nap M., Jornvall H., and Schutte B. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J. Pathol. 187 (1999) 567-572
10. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
11. Menezes S.L.S., Bozza P.T., Faria Neto H.C.C., Laranjeira A.P., Negri E.M., Capelozzi V.L., Zin W.A., and Rocco P.R.M. Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses. J. Appl. Physiol. 98 (2005) 1777-1783
12. Brigham K.L., and Meyrick B. Endotoxin and lung injury. Am. Rev. Respir. Dis. 133 (1986) 913-927
13. Martin M., Schifferle R.E., Cuesta N., Vogel S.N., Katz J., and Michalek S.M. Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J. Immunol. 171 (2003) 717-725
14. Dumitru C.D., Ceci J.D., Tsatsanis C., Kontoyiannis D., Stamatakis K., Lin J.H., Patriotis C., Jenkins N.A., Copeland N.G., Kollias G., and Tsichlis P.N. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103 (2000) 1071-1083
15. Hippenstiel S., Soeth S., Kellas B., Fuhrmann O., Seybold J., Krull M., Eichel-Streiber C., Goebeler M., Ludwig S., and Suttorp N. Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells. Blood 95 (2000) 3044-3051
16. Elices M.J., Osborn L., Takada Y.L., Crouse C., Luhoowskyi S., Helmer M.E., and Lobb R.R. VCAM-1 on activated endothelium interacts with the specific leukocyte integrin VLA-4 at a site distinct from VLA-4/fibronectin binding site. Cell 60 (1990) 577-584
17. Katzenstein A.L., Bloor C.M., and Leibow A.A. Diffuse alveolar damage - the role of oxygen, shock, and related factors. A review. Am. J. Pathol. 85 (1976) 209-228
18. Lutz C., Carney D., Finck C., Picone A., Gatto L.A., Paskanik A., Langenback E., and Nieman G. Aerosolized surfactant improves pulmonary function in endotoxin-induced lung injury. Am. J. Respir. Crit. Care Med. 158 (1998) 840-845
19. Ingenito E.P., Mora R., Cullivan M., Marzan Y., Haley K., Mark L., and Sonna L.A. Decreased surfactant protein-B expression and surfactant dysfunction in a murine model of acute lung injury. Am. J. Respir. Cell Mol. Biol. 25 (2001) 35-44
20. Kitamura Y., Hashimoto S., Mizuta N., Kobayashi A., Kooguchi K., Fujiwara I., and Nakajima H. Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. Am. J. Respir. Crit. Care Med. 163 (2001) 762-769
21. Wagner K.F., Hellberg A.K., Balenger S., Depping R., Dodd O., Johns R.A., and Li D. Hypoxia-induced mitogenic factor has antiapoptotic action and is upregulated in the developing lung: coexpression with hypoxia-inducible factor-2{α}. Am. J. Respir. Cell Mol. Biol. 31 (2004) 276-282